Skip to content
May 14, 2024

Equity.Guru

Investment information for the new generation

Search

Arizona cannabis

Venom Extracts, a subsidiary of Hollister Biosciences (HOLL.C), hit their second and final revenue milestone on December 9th, 2020, by pulling in CAD$40 million in revenue, starting from January…
HARV’s Arizona revenues would likely get turbo-charged when/if the state flips to legal recreational cannabis….
Vext Science (VEXT.C) acquired the occupancy certificate for a second dispensary in northern Phoenix today, which will be leased out to the Organica Patient Group Medical Marijuana Dispensary. The…
“Medical marijuana dispensary owners who opted to expand into the adult-use market largely would do so in their existing physical locations,” stated The Phoenix New Times, “adding new staff…
Last week Hollister Biosciences (HOLL.C) signed a letter of intent to acquire Arizona-based award-winning medical cannabis distillate and related product extraction brand, Venom Extracts, in an all stock deal…
“The core business, which is derived from an Arizona licensed vertically integrated model, generated USD $13 million in revenues during the first two quarters of 2019,” confirmed Equity Guru’s…